Clinical Trial

Augmented Reality-Based Aromatherapy Education for Older Adults With Early-Stage Dementia in Taiwan

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates an augmented reality (AR)-based aromatherapy education program designed for older adults with early-stage dementia in Taiwan. Participants are randomly assigned to either the intervention group, which receives AR-supported aromatherapy education sessions, or a comparison group receiving standard activities. The primary objective is to assess changes in neuropsychiatric symptoms and psychological well-being. Secondary outcomes include cognitive function and quality of life. The study aims to explore the feasibility and potential clinical benefits of integrating digital technology with non-pharmacological dementia care approaches.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-18.
Trial Details
NCT Number NCT07431164
Lead Sponsor National Taiwan Normal University
Conditions Dementia, Mild Cognitive Impairment (MCI), Neuropsychiatric Symptoms
Enrollment 300 participants
Start Date 2025-05-23
Primary Completion 2025-10-30 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-09